Drucken


FRESENIUS SE & CO. KGAA INHABER-AKTIEN O.N.

23.04.2018 - 16:53

DGAP-Adhoc: Fresenius SE & Co. KGaA: Akorn, Inc. sues Fresenius for consummation of merger agreement after its termination by Fresenius



DGAP-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Mergers & Acquisitions/Legal Matter


Fresenius SE & Co. KGaA: Akorn, Inc. sues Fresenius for consummation of merger agreement after its termination by Fresenius


23-Apr-2018 / 16:53 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Akorn, Inc. sues Fresenius for consummation of merger agreement after its termination by Fresenius


Akorn, Inc. filed a lawsuit today against Fresenius at the Court of Chancery in Delaware, USA, for the consummation of the merger agreement.



Akorn, Inc. argues that Fresenius was obliged to close the transaction because all closing conditions of the merger agreement, except FTC clearance, were met.



Fresenius believes that the lawsuit is without foundation, because Akorn failed to fulfill several closing conditions. Among others, Fresenius' independent investigation found material breaches of FDA1 data integrity requirements relating to Akorn's operations. Fresenius will take all necessary and appropriate measures to vigorously contest the claims.



Fresenius does not intend to provide further updates as the lawsuit proceeds.

 



1 FDA: Food and Drug Administration

 



Fresenius SE & Co. KGaA,

represented by Fresenius Management SE,

The Management Board



Bad Homburg v.d.H., April 23, 2018

----------------------------------------

Contact:

Markus Georgi

Senior Vice President Investor Relations

T: +49 (0) 6172 608-2485

markus.georgi@fresenius.com

----------------------------------------



End of note











23-Apr-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



























Language: English
Company: Fresenius SE & Co. KGaA

Else-Kröner-Straße 1

61352 Bad Homburg v.d.H.

Germany
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: ir-fre@fresenius.com
Internet: www.fresenius.com
ISIN: DE0005785604, DE000A2DANS3
WKN: 578560 , A2DANS
Indices: DAX
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxemburg





 
End of Announcement DGAP News Service




677783  23-Apr-2018 CET/CEST







fncls.ssp?fn=show_t_gif&application_id=677783&application_name=news&site_id=real_vwd

Zeit Kurs Vortag 1 Jahr
FRESENIUS SE+CO.KGAA... 21:55 61,94 -0,23 -8,82%
sponsored by

Mehr Marktdaten und Kurse finden Sie auf www.finanztreff.de